IFNG and neoplasm: Several different tumor types express PD-L1 either due to up-regulation after mutations in the PD-L1 gene (CD274) or as a result of adaptive up-regulation after stimulation with inflammatory cytokines (i.e., interferon-gamma (IFNγ)) present in the microenvironment [76,77].